Cancer cells with high NRF2 activity were less sensitive to cytotoxic chemotherapeutics such as cisplatin, doxorubicin, and 5-fluorouracil through facilitated detoxification of anticancer agents and enhanced antioxidant capacity [101]. This evidence concerns the gene NFE2L2 and cancer.